Brief: Solvonis Therapeutics Says Engaged with Pharmaventures To Support Commercialisation Of Two Clinical-Stage Programmes

Solvonis Therapeutics

04/04/2025 07:09

April 4 (Reuters) - Solvonis Therapeutics PLC SVNS.L:

SOLVONIS THERAPEUTICS -  ENGAGED PHARMAVENTURES TO SUPPORT COMMERCIALISATION OF TWO CLINICAL-STAGE PROGRAMMES, AWKN-001 AND AWKN-002

SOLVONIS THERAPEUTICS - COMMERCIAL POTENTIAL OF TWO CLINICAL-STAGE PROGRAMMES WITH POTENTIAL VALUE BASED ON COMPARABLE ASSETS OF MORE THAN £200 MILLION

Source text: ID:nRSD5966Da

Further company coverage: SVNS.L

 ((Reuters.Briefs@thomsonreuters.com;))